BioAge Labs, Inc. 10-K filing
Filed 2026-03-24 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-120873
- Form type
- 10-K
- CIK
- 0001709941
- Primary document
- https://www.sec.gov/Archives/edgar/data/1709941/000119312526120873/bioa-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioAge Labs, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $9.0M | - | - |
| Operating Income | $-92.8M | - | - |
| Net Income | $-80.6M | - | - |
| Eps Basic | -2.24 | - | - |
| Eps Diluted | -2.24 | - | - |
| Cash And Equivalents | $188.9M | - | - |
| Total Assets | $294.9M | - | - |
| Total Liabilities | $22.8M | - | - |
| Shareholders Equity | $272.1M | - | - |
| Operating Cash Flow | $-81.6M | - | - |
| Capital Expenditures | $719,000 | - | - |